Nix v. Major League Baseball

62 F.4th 920
CourtCourt of Appeals for the Fifth Circuit
DecidedMarch 16, 2023
Docket22-20364
StatusPublished
Cited by26 cases

This text of 62 F.4th 920 (Nix v. Major League Baseball) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nix v. Major League Baseball, 62 F.4th 920 (5th Cir. 2023).

Opinion

Case: 22-20364 Document: 00516679659 Page: 1 Date Filed: 03/16/2023

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

FILED March 16, 2023 No. 22-20364 Lyle W. Cayce Clerk

Neiman Nix, Plaintiff—Appellant, versus Major League Baseball, Office of the Commissioner of Baseball; Robert D. Manfred, Jr.; Major League Baseball Players Association; Angels Baseball L.P.; Athletics Investment Group L.L.C., also known as Oakland Athletics Baseball Company; AZPB Limited Partnership; Associated Press, Incorporated; Howie Rumberg; ESPN, Incorporated; USA Today, Incorporated; NSF International; The Gatorade Company; NFI Consumer Products; Cytosport, Incorporated; Klean Athlete; Informed Choice; Zachary 1 Grant Antero Britton; John and Jane Doe (1-10); et al.,

Defendants—Appellees.

1 In 2019, Britton expressed his desire to be known as “Zack” (derived from his birth and legal name, “Zackary”) rather than “Zach” (his professional name up to that point). See Associated Press, Yankees Reliever Zack Britton Now Using Legal Spelling of First Name, ESPN (Feb. 11, 2019), https://www.espn.com/mlb/story/_/id/25974959/ yankees-reliever-zack-britton-now-using-legal-spelling-first-name. This opinion uses Britton’s legal name, “Zackary.” Case: 22-20364 Document: 00516679659 Page: 2 Date Filed: 03/16/2023

No. 22-20364

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:21-CV-4180

Before Smith, Clement, and Wilson, Circuit Judges. Jerry E. Smith, Circuit Judge: This appeal involves the latest in a series of unsuccessful lawsuits 2 by Neiman Nix, proceeding pro se, who sued Major League Baseball (“MLB”), the MLB Player’s Association (“MLBPA”), and numerous other defendants, including media companies and nutritional companies. 3 Nix strikes out once again. Accordingly, we affirm and grant the defen- dants’ motion for sanctions.

2 Viz., Nix v. MLB, No. 14-004294-CA-01 (Fla. 11th Cir. Ct. Feb. 18, 2014); Nix v. MLB, No. 16-cv-5604 (S.D.N.Y. July 14, 2016); Nix v. MLB, No. 17-cv-1241 (S.D.N.Y. Feb. 17, 2017); Nix v. MLB, No. 159953/2016 (N.Y. Sup. Ct. Nov. 28, 2016); Nix v. Luhnow, No. 50-2018-CA-3920 (Fla. 15th Cir. Ct. Apr. 2, 2018); Nix v. ESPN, Inc., No. 18-cv-22208 (S.D. Fla. June 4, 2018); Nix v. MLB, No. 2019-2611-CA-01 (Fla. 11th Cir. Ct. Jan. 25, 2019); DNA Sports Performance Lab, Inc. v. MLB, No. 3:20-cv-546-WHA (N.D. Cal. Jan. 23, 2020). 3 The defendants fall into four categories: First, the MLB-related defendants, including MLB; MLB Commissioner Robert D. Manfred, Jr.; MLB employee Tim Maxey (although the complaint labels him a “Nutritional Defendant”); and thirty MLB Clubs. Second, the MLBPA-related defendants, including the MLBPA and MLBPA Executive Committee member Zackary Britton. Third, the “Media Defendants,” including the Associated Press (“AP”); ESPN; USA Today; and Howie Rumberg, an AP editor during the relevant time period. Fourth, the “Nutritional Defendants,” entities that produce, sell, or test nutritional products, including the Gatorade Company; CytoSport; NSF Interna- tional; HVL LLC; LGC Science; Klean Athlete; and NFI Consumer Products (“Blue- Emu”).

2 Case: 22-20364 Document: 00516679659 Page: 3 Date Filed: 03/16/2023

I. A. The following core facts are taken from Nix’s complaint except for the dispositions of his prior lawsuits, which are subject to judicial notice. Nix is a former professional baseball player whose defunct company, DNA Sports Performance Lab, Inc., sold and distributed natural animal substances. In 2013, MLB and the MLBPA began an investigation into the sale and use of performance-enhancing drugs; Nix and his company were among those investigated. Since then, Nix has filed a series of lawsuits across the country against MLB, the MLBPA, their members and employees, and an increasing number of assorted defendants. As of 2015, the Joint Drug and Prevention Treatment Program (“Joint Drug Agreement”), which defines impermissible drug usage by MLB players, has banned insulin-like growth factor (“IGF-1”) as a prohibited substance. The natural form of IGF-1 is required for human survival and occurs in detec- table quantities in a wide variety of everyday food and drink, including meat and milk. The ban, per MLB, includes all-natural, synthetic, and bioidentical versions of IGF-1. Nix claims that the ban is “fake” and selectively enforced. As the complaint interprets the ban, it is absolute: Despite that IGF-1 is necessary for survival, any player who consumes anything with even a quantum of IGF-1 violates the ban. Nix alleges that he is being unfairly targeted because MLB has not suspended every player who has consumed any natural or synthetic product that contains any “bio-available” level of IGF-1 and has targeted him for selling products containing IGF-1. In 2016, Nix sued MLB and related defendants in the Southern Dis- trict of New York for tortious interference with current and prospective busi- ness relationships. Various news agencies, including the Media Defendants,

3 Case: 22-20364 Document: 00516679659 Page: 4 Date Filed: 03/16/2023

reported on the suits. An article originally published by the AP and repub- lished by other Media Defendants stated that in his suit, Nix had admitted that his company sold products containing IGF-1. Nix then sued the AP, ESPN, and USA Today in the Southern District of Florida, claiming that the published statement was defamatory. During that lawsuit, Nix was informed that MLB had confirmed to the AP that the ban on IGF-1 did not distinguish based on type (i.e., natural versus synthetic). The district court dismissed the case. In response to that dismissal, an AP sports editor, Howie Rumberg, emailed an MLB employee and said, “Not sure you even remember helping me with a few things on a defamation case involving PED [i.e., performance-enhancing drug] producer Neiman Nix but wanted to let you know his suit was tossed out of court.” Nix alleges that statement was defamatory. Nix then sued MLB and other defendants in several state and federal courts, including New York state court and California federal court. The court in California found that Nix failed to state any claim under Rule 12(b)(6) but allowed him to amend his complaint. Nix declined and dismissed with prejudice. The court then sanctioned Nix and his company; Nix has yet to pay the sanctions. Throughout the years of litigation, MLB and the MLBPA have either continued or started sponsorship and promotional relationships with numer- ous Nutritional Defendants. For example, CytoSport advertises its Muscle Milk products using the likenesses of numerous MLBPA members and the trademarked logos of MLB clubs. Likewise, MLB announced a sponsorship agreement with Blue-Emu, which then marketed some of its products as the “official” ones of the MLB. Moreover, numerous products were tested and labeled “certified for sport” by defendant NSF. We come to the lawsuit at issue here, which alleges nine causes of

4 Case: 22-20364 Document: 00516679659 Page: 5 Date Filed: 03/16/2023

action: (i) civil RICO claims against all defendants; (ii) fraud claims against all defendants; (iii) defamation claims against the AP and Rumberg; (iv) aid- ing and abetting claims against ESPN, the AP, USA Today, Tim Maxey, Zackary Britton, Muscle Milk, and Klean Athlete; (v) Lanham Act claims against Gatorade, NSF, Blue-Emu, Informed Choice, and numerous MLB Clubs; (vi) vicarious liability claims against Gatorade, NSF, and Britton; (vii) tortious interference claims against MLB and the MLBPA; (viii) unjust enrichment claims against all defendants; and (ix) mental anguish claims against all defendants. Nix’s core legal theory is that the defendants have selectively enforced the “fake” IGF-1 ban against him and no one else.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
62 F.4th 920, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nix-v-major-league-baseball-ca5-2023.